VSTM
Price:
$3.905
Market Cap:
$173.80M
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylate MEK. The company also engages in developing RAMP 201, an adaptive two-part multicenter, parallel cohort, randomized open label trial to evaluate the efficacy and safety of VS-6766 and in combination with defactinib, an oral small molecule inhibitor of focal adhesion kinase (FAK) in patients with recurrent low grade serous ovarian cancer; and RAMP 20...[Read more]
Industry
Biotechnology
IPO Date
2012-01-27
Stock Exchange
NASDAQ
Ticker
VSTM
According to Verastem, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.23. This represents a change of -21.07% compared to the average of 4.09 of the last 4 quarters.
The mean historical Current Ratio of Verastem, Inc. over the last ten years is 6.75. The current 3.23 Current Ratio has changed 4.68% with respect to the historical average. Over the past ten years (40 quarters), VSTM's Current Ratio was at its highest in in the March 2016 quarter at 16.42. The Current Ratio was at its lowest in in the December 2019 quarter at 2.84.
Average
6.75
Median
6.26
Minimum
2.84
Maximum
11.04
Discovering the peaks and valleys of Verastem, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 198.31%
Maximum Annual Current Ratio = 11.04
Minimum Annual Increase = -58.39%
Minimum Annual Current Ratio = 2.84
Year | Current Ratio | Change |
---|---|---|
2023 | 5.45 | 27.05% |
2022 | 4.29 | -24.63% |
2021 | 5.69 | -32.92% |
2020 | 8.48 | 198.31% |
2019 | 2.84 | -58.39% |
2018 | 6.83 | 33.27% |
2017 | 5.13 | -30.71% |
2016 | 7.40 | -33.00% |
2015 | 11.04 | 6.61% |
2014 | 10.36 | -20.73% |
The current Current Ratio of Verastem, Inc. (VSTM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
5.14
5-year avg
5.35
10-year avg
6.75
Verastem, Inc.’s Current Ratio is less than Viking Therapeutics, Inc. (36.47), greater than Trevena, Inc. (2.42), greater than Karyopharm Therapeutics Inc. (3.00), less than AcelRx Pharmaceuticals, Inc. (4.42), greater than Infinity Pharmaceuticals, Inc. (2.96),
Company | Current Ratio | Market cap |
---|---|---|
36.47 | $4.71B | |
2.42 | $1.55M | |
3.00 | $75.10M | |
4.42 | $14.58M | |
2.96 | $726.09K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Verastem, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Verastem, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Verastem, Inc.'s Current Ratio?
How is the Current Ratio calculated for Verastem, Inc. (VSTM)?
What is the highest Current Ratio for Verastem, Inc. (VSTM)?
What is the 3-year average Current Ratio for Verastem, Inc. (VSTM)?
What is the 5-year average Current Ratio for Verastem, Inc. (VSTM)?
How does the current Current Ratio for Verastem, Inc. (VSTM) compare to its historical average?